From the inventory of a cell by –omics to synthetic biology, from strain development to industrial biotechnological processes including downstream processing
Production, analytics & regulatory aspects of advanced therapy medicinal products
Anreise-informationen das Programm zum Download Additive Fertigung und insbesondere der 3D-Druck gelten als "Game Changer" für viele...
The Subject Division Plant based Extracts - Products and Processes of ProcessNet (an initiative of DECHEMA – Society for Chemical Engineering and...
New production systems and innovative manufacturing methods such as single-use technologies bring about new challenges for quality control of biopharmaceutical production processes. In its most recent publication, the DECHEMA Working Group “Single-use technology in biopharmaceutical manufacturing” gives recommendations for a risk analysis of these processes. Based on prior publications, the compact paper lists the regulatory background as well as potential risks related to material, processes, or products. An example of an industrial application shows how risk values can be defined and risk levels calculated in order to determine appropriate countermeasures. This recommendation is based on an article in Adv. Biochem. Eng. Biotechnol. The original publication is available at www.springerlink.com.
Bioflavour 2015 - International Conference on Flavour and Fragrance Biotechnology
The 2 nd European Conference on Natural Products will again bring together more than 300 international experts in secondary metabolite research. The...
> Download programme as PDF Enzymes are considered to be little miracle substances for innovation, process advantages and cost...
DECHEMA-Werkstoff-Tabelle (materials charts) - the ultimate reference for corrosion specialists materials scientists...